Hematologic Findings of Inherited Metabolic Disease: They are More Than Expected. Issue 5 (July 2018)

• Record Type: Journal Article
• Authors: Sal, Ertan; Yenicesu, Idil; Okur, Ilyas; Kaya, Zuhre; Ezgu, Fatih S.; Kocak, Ulker; Tumer, Leyla; Gursel, Turkiz; Hasanoglu, Alev
• Is Part Of: Journal of pediatric hematology/oncology. Volume 40:Issue 5(2018)
• Publication Date: 2018-07
• Subjects: metabolic disease -- anemia -- neutropenia -- thrombocytosis; Pediatric hematology -- Periodicals; Tumors in children -- Periodicals; 618.9215
• DOI: 10.1097/MPH.0000000000001206
• Languages: English
• ISSNs: 1077-4114

Abstract

Abstract : Inherited metabolic diseases are pathologic conditions that generally develop as a result of impairment of the production or breakdown of protein, carbohydrate, and fatty acids. Early determination of hematological findings has a positive effect on the prognosis of metabolic diseases. Three hundred eighteen patients who were being followed-up within the previous 6 months at Department of Pediatric Nutrition and Metabolism, Gazi University, Turkey, were included in the study. The hematological findings were classified under 7 main groups: anemia of chronic disease, iron deficiency anemia, vitamin B12 deficiency anemia, hemophagocytosis, leukocytosis, and thrombocytosis. Nine hundred twenty-two hematological examinations of the 319 patients were included in the study, and 283 hematological findings were determined, 127 anemia of chronic disease, 81 iron deficiency anemia, 56 cytopenia, and 4 vitamin B12 deficiency anemia. Leukocytosis (n=1), thrombocytosis (n=5), and hemophagocytosis (n=9) were also observed. It was determined that, although anemia of chronic disease and nutritional anemia are the most common hematological findings, these may be diagnosed late, whereas neutropenia, thrombocytopenia, pancytopenia, and hemostasis disorders may be diagnosed earlier. Our study is the most comprehensive one in the literature, and we think it would positively contribute to the monitoring and prognosis of congenital metabolic diseases.